Published 2023 | Version v1
Publication

Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity

Additional details

Created:
February 14, 2024
Modified:
February 14, 2024